Singapore-based health tech company Rebee Health raised undisclosed amount of funding from 1337 Ventures through its seed-stage fund, 1337 Capital 1, to scale its AI-powered rehabilitation platform and wearable sensor technology. The investment will enable Rebee to expand into more hospitals, clinics, and homes; strengthen collaborations with healthcare providers; and accelerate the development of AI-driven patient monitoring tools.
“As the demand for rehabilitation grows, innovative solutions like Rebee Health’s wearable technology are critical to improving patient outcomes while reducing strain on healthcare systems. We see Rebee as a game-changer in digital physiotherapy, making recovery more accessible, efficient and scalable,” said Bikesh Lakhmichand, CEO and founding partner of 1337 Ventures.
With the global aging population on the rise, the demand for physical rehabilitation is set to increase dramatically. More individuals will require long-term care for chronic conditions, post-surgical recovery, and injury rehabilitation. However, the rehabilitation ecosystem remains highly complex and expensive, often requiring frequent in-person therapy sessions that place a burden on patients, caregivers and healthcare providers, reports 1337 Ventures.
Wearable sensor technology is being used by Rebee Health to address this issue and transform the rehabilitation process. Real-time, remote physiotherapy sessions are made possible by its physiotherapy system, which increases accessibility, cost effectiveness, and data-driven rehabilitation. The wearable sensor at the heart of Rebee's solution gathers biomechanical data from patients as they exercise.
The patient application receives this data and uses it to track progress and provide real-time insights on when and how to perform exercises correctly. Healthcare professionals can simultaneously watch patients remotely through the therapist web portal, facilitating real-time decision-making and cutting down on needless in-person visits. Significant cost reductions for healthcare institutions could result from the large-scale use of Rebee's system in Singapore.
Read more PhotoniCare Secures $4.6 Million
“As the demand for rehabilitation grows, innovative solutions like Rebee Health’s wearable technology are critical to improving patient outcomes while reducing strain on healthcare systems. We see Rebee as a game-changer in digital physiotherapy, making recovery more accessible, efficient, and scalable,” said Bikesh Lakhmichand, CEO and founding partner of 1337 Ventures.
With this funding, Rebee Health aims to expand its wearable rehabilitation solutions to more hospitals, clinics, and direct consumers, develop AI-driven rehabilitation to enhance patient engagement and recovery, and strengthen data insights for remote decision-making to improve patient outcomes and reduce costs.
The 1337 Capital 1 Fund is a sector-agnostic seed-stage fund backed by industry leaders like Suresh Thiru, former COO of JobStreet, and successful startup founders. Designed by entrepreneurs for entrepreneurs, the fund provides early-stage startups with funding, mentorship, and strategic guidance, accelerating the next wave of disruptive innovation.
